The Ritedose Corporation recalls Formoterol Fumarate Inhalation Solution
- Published
- 4 Nov 2026
- Units affected
- 3210 Cartons
- Agency
- FDA
- Country
- United States
The hazard
Failed Impurities/Degradation Specification
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Formoterol Fumarate Inhalation Solution, 20mcg/2mL, packaged in cartons of 30 individually wrapped vials (NDC 76204-030-01) and 60 individually wrapped vials (NDC 76204-030-02), Rx only, Manufactured for and by: Ritedose Pharmaceuticals, LLC, Columbia, SC
- Brand / company
- The Ritedose Corporation
- Codes / lots
- Lot: 25BL0, Expires: 02/28/2027
- Distribution
- Nationwide within the U.S
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 4 Nov 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.